Trial intelligence / Profile preview

Autologous platelet-rich fibrin for healing after CWD mastoidectomy

IRCT20211010052721N3Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Mar 2021
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of platelet rich fibrin in Mastoiditis (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Duration of eardrum epithelialization. Started Mar 2021; status: completed.

02

Drugs

platelet rich fibrin
03

Conditions

Mastoiditis

Beyond the preview

Go deeper on IRCT20211010052721N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20211010052721N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call